{
    "2018-02-01": [
        [
            {
                "time": "2018-01-03",
                "original_text": "Top 4 Marijuana Stocks to Watch",
                "features": {
                    "keywords": [
                        "Marijuana",
                        "Stocks",
                        "Watch"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-31",
                "original_text": "5 Best Performing Stocks of January",
                "features": {
                    "keywords": [
                        "Best",
                        "Performing",
                        "Stocks",
                        "January"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-16",
                "original_text": "A Look at Analysts’ Estimates for Johnson & Johnson",
                "features": {
                    "keywords": [
                        "Analysts",
                        "Estimates",
                        "Johnson & Johnson"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-25",
                "original_text": "Will Gilead (GILD) Disappoint Investors in Q4 Earnings?",
                "features": {
                    "keywords": [
                        "Gilead",
                        "Disappoint",
                        "Investors",
                        "Q4",
                        "Earnings"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-23",
                "original_text": "Merck’s 4Q17 Estimates: Animal Health",
                "features": {
                    "keywords": [
                        "Merck",
                        "4Q17",
                        "Estimates",
                        "Animal",
                        "Health"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-29",
                "original_text": "Biotech Stock Roundup: AbbVie 4Q Results Impress, Ablynx to be Acquired by Sanofi",
                "features": {
                    "keywords": [
                        "Biotech",
                        "Stock",
                        "AbbVie",
                        "4Q",
                        "Results",
                        "Ablynx",
                        "Sanofi"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-18",
                "original_text": "Wired News – Shire Secured Exclusive Worldwide License to Develop and Commercialize AB Biosciences’ PRIM Program",
                "features": {
                    "keywords": [
                        "Shire",
                        "Exclusive",
                        "Worldwide",
                        "License",
                        "Develop",
                        "Commercialize",
                        "AB Biosciences",
                        "PRIM Program"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-15",
                "original_text": "Cramer Remix: Here are the best-in-show biotechs for 2018...",
                "features": {
                    "keywords": [
                        "Cramer",
                        "Remix",
                        "best-in-show",
                        "biotechs",
                        "2018"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-22",
                "original_text": "Cramer Remix: AbbVie and Biogen are the best-in-show biotechs for 2018 so far",
                "features": {
                    "keywords": [
                        "Cramer",
                        "Remix",
                        "AbbVie",
                        "Biogen",
                        "best-in-show",
                        "biotechs",
                        "2018"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}